This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 Aug;39(4):451-452.

doi: 10.1016/j.accpm.2020.07.003. Epub 2020 Jul 9.

Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?

Karim Bendjelid¹, Raphael Giraud², Stephan Von Düring³

Affiliations

Affiliations

¹ Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address: karim.bendjelid@hcuge.ch.
² Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.
³ Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

PMID: 32653550
PMCID: PMC7347339
DOI: 10.1016/j.accpm.2020.07.003

Editorial

Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?

Karim Bendjelid et al. Anaesth Crit Care Pain Med. 2020 Aug.

. 2020 Aug;39(4):451-452.

doi: 10.1016/j.accpm.2020.07.003. Epub 2020 Jul 9.

Authors

Karim Bendjelid¹, Raphael Giraud², Stephan Von Düring³

Affiliations

¹ Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address: karim.bendjelid@hcuge.ch.
² Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.
³ Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

PMID: 32653550
PMCID: PMC7347339
DOI: 10.1016/j.accpm.2020.07.003

No abstract available

Keywords: Almitrine; COVID-19; Capillary shunt; Hypoxemia.

PubMed Disclaimer

References

1. Tobin M.J. Basing respiratory management of COVID-19 on physiological principles. Am J Resp Crit Care Med. 2020;201(11):1319–1320. - PMC - PubMed
1. Gattinoni L., Coppola S., Cressoni M., Busana M., Rossi S., Chiumello D. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Resp Crit Care Med. 2020;201(10):1299–1300. - PMC - PubMed
1. Marini J.J., Gattinoni L. Management of COVID-19 respiratory distress. Jama. 2020 - PubMed
1. Bendjelid K., Raphael G. Treating hypoxemic patients with SARS-COV-2 pneumonia: back to applied physiology. Anaesth Crit Care Pain Med. 2020 - PMC - PubMed
1. Naeije R., Brimioulle S. Physiology in medicine: importance of hypoxic pulmonary vasoconstriction in maintaining arterial oxygenation during acute respiratory failure. Critical care. 2001;5(2):67–71. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Europe PubMed Central
Other Literature Sources
- The Lens - Patent Citations Database